Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Neuro-Oncology|May 24, 2022
Dysfunctional dendritic cells limit antigen-specific T cell response in gliomaMirco Friedrich, Markus Hahn, Julius Michel, et al.Neuro-Oncology Advances|November 5, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodesJens Blobner, Michael Kilian, Chin Leng Tan, et al.Neuro-Oncology Advances|October 5, 2022
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cellsKevin Hai-Ning Lu, Julius Michel, Michael Kilian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2021
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental GliomasMichael Kilian, Mirco Friedrich, Khwab Sanghvi, et al.Cancer Cell|March 10, 2023
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsMirco J Friedrich, Paola Neri, Niklas Kehl, et al.Neuro-Oncology|September 16, 2023
NLGN4X TCR transgenic T cells to treat gliomasChristoper Krämer, Michael Kilian, Yu-Chan Chih, et al.Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.Journal for Immunotherapy of Cancer|October 17, 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, et al.Theranostics|November 1, 2023
<i>In vivo</i> nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.Pageof 3